Inactive Instrument

STRATA Skin Sciences Inc Share Price Nasdaq

Equities

US86272A1079

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq
- USD - Intraday chart for STRATA Skin Sciences Inc
Sales 2024 * 3.12Cr 259.71Cr Sales 2025 * 3.38Cr 281.84Cr Capitalization 1.08Cr 90Cr
Net income 2024 * -1Cr -83Cr Net income 2025 * -50L -42Cr EV / Sales 2024 * 0.35 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.32 x
P/E ratio 2024 *
-1.1 x
P/E ratio 2025 *
-1.98 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 59.41%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 60 10/18/10
Director of Finance/CFO 42 06/21/06
Chief Operating Officer - 01/15/01
Members of the board TitleAgeSince
Chairman 56 29/18/29
Chief Executive Officer 60 10/18/10
Director/Board Member 60 29/18/29
More insiders
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
More about the company